Polypharmacy Surge Among Older Americans Reveals Drug Interaction Risks

A comprehensive new study examining medication patterns among older Americans has revealed a troubling trend: prescription drug and dietary supplement use continues to climb while over-the-counter medication usage has declined, creating an expanding landscape of potential drug-drug interactions in one of healthcare's most vulnerable populations.

According to the research, which analyzed data spanning 2015 to 2023 using the Cerner-Multum Lexicon Plus database, over-the-counter medication use among older adults dropped from 60% to 55% during this period. Meanwhile, prescription medication and supplement usage increased, contributing to a phenomenon known as polypharmacy—the concurrent use of multiple medications by a single patient.

Understanding the Polypharmacy Problem

The findings underscore a growing public health challenge as America's population ages. Healthcare professionals define polypharmacy as the use of five or more medications simultaneously, though some experts use different thresholds. The practice becomes particularly concerning among older adults who often manage multiple chronic conditions requiring pharmaceutical intervention.

"The shift we're observing represents a fundamental change in how older Americans are managing their health," the study's methodology suggests. By leveraging the Cerner-Multum Lexicon Plus database—a comprehensive clinical resource that catalogs drug interactions, side effects, and contraindications—researchers were able to identify potentially dangerous combinations that might otherwise go unnoticed in routine clinical practice.

Key findings from the research include:

• Daily or weekly use of prescription medications increased significantly among the elderly cohort
• Dietary supplement consumption rose in parallel with prescription drug use
• OTC medication usage declined by 5 percentage points over the eight-year period
• Multiple opportunities for dangerous drug-drug interactions were identified across the study population

The Hidden Dangers of Drug Interactions

The rise in polypharmacy creates a complex web of potential interactions that can diminish medication effectiveness, cause adverse side effects, or create entirely new health risks. Common scenarios include blood thinners interacting with supplements like ginkgo biloba, statins conflicting with certain antibiotics, or diabetes medications amplifying the effects of other drugs.

What makes this trend particularly concerning is that many older adults see multiple specialists who may not have complete visibility into their full medication regimen. A cardiologist prescribing heart medication may not know about the arthritis drugs prescribed by a rheumatologist, or the over-the-counter supplements a patient started taking on their own initiative.

The decline in OTC medication use might initially seem positive, but experts caution it could indicate patients are turning to prescription alternatives for conditions that might be safely managed with over-the-counter options—potentially adding unnecessary complexity to their medication regimens. Using tools like PharmoniQ's interaction checker can help identify these hidden risks before they become health emergencies.

Industry and Clinical Response

The pharmaceutical industry and healthcare providers are beginning to respond to these findings with renewed focus on medication reconciliation and patient education. Clinical pharmacists are increasingly being integrated into care teams specifically to review complex medication regimens and identify potential interactions.

Healthcare technology companies are also developing more sophisticated clinical decision support systems that can flag dangerous combinations in real-time. These systems draw on databases similar to the Cerner-Multum Lexicon Plus used in this research, providing prescribers with immediate alerts when new medications might interact with existing therapies.

Several major health systems have implemented comprehensive medication review programs, where clinical pharmacists conduct regular assessments of patients taking multiple medications. These programs have shown promising results in reducing adverse drug events and hospitalizations among older adults.

Looking Ahead: Balancing Treatment and Safety

As the research makes clear, the challenge ahead involves maintaining necessary treatments for multiple chronic conditions while minimizing the risks associated with polypharmacy. This will require a multi-faceted approach involving patients, prescribers, pharmacists, and caregivers.

Patients and their families should maintain complete, updated lists of all medications and supplements—including dosages and frequency. Before starting any new medication or supplement, consulting resources like comprehensive supplement databases can provide critical safety information about potential interactions.

For healthcare providers, the findings emphasize the importance of regular medication reviews, especially for older patients managing multiple conditions. The data from 2015 to 2023 suggests this isn't a temporary trend but rather a sustained shift in medication patterns that requires systematic clinical attention.

Moving forward, researchers and clinicians alike are calling for improved coordination of care, better health information exchange systems, and enhanced patient education about the risks of polypharmacy. As prescription drug and supplement use continues to rise among older Americans, addressing drug interaction risks will become increasingly critical to ensuring safe, effective healthcare for this growing population segment.